Hennepin Health’s Quality Management Committee formally adopted five medical, three behavioral health and two substance use clinical practice guidelines from nationally or locally recognized sources.
The MN Department of Human Services (DHS) has compiled a list of frequently asked questions for providers regarding the Uniform Preferred Drug List.
Beginning January 1, 2019, all personal care assistance (PCA) and home care nursing (HCN) services for people under age 65 will be covered under fee-for-service (FFS), and will be paid by the Department of Human Services (DHS).
Effective 1/04/2019, Hennepin Health will attempt to correct errors found in the subscriber name fields of incoming 837 claim transactions.
Hennepin Health’s prior authorization document is ready and available for review.
Hennepin Health will transition from the Rule 25 chemical dependency system to a direct access system, also referred to by its Minnesota Statute reference number Chapter 245G. This transition is taking place in a parallel process as Rule 25 and direct access treatment services are both covered until July 1, 2020 when Rule 25 will end.
HennepIn Health has completed its annual 2018 HEDIS measure reporting.
Hennepin Health has been informed of three separate drug recalls. All three recalls were made voluntarily by the drug manufacturers.
As of August 1, 2018, Hennepin Health began testing incoming transactions for compliance under SNIP Levels 4 and 5 requirements. This new implementation will allow for faster processing of clean claims and improved data quality with fewer data cycle errors. Beginning September 1, 2018, claims will reject if they do not pass SNIP Levels 4 and 5 testing.
On July 12, 2018, Hennepin Health’s claims system was enhanced to include the use of Optum Claim Edit System™ (CES) software. The enhancement is applicable for all new and adjusted professional (837P) and institutional (837I) claims for Hennepin Health-PMAP, Hennepin Health-MNCare and Hennepin Health-SNBC members.
The Minnesota Department of Health (MDH) has made several updates clarifying the requirements for Child & Teen Checkup (C&TC) screenings. These updates went into effect June 1, 2018 and have been incorporated into the C&TC fact sheets available on MDH’s website.
Hennepin Health has made several changes to its drug formulary that are applicable to Hennepin Health-PMAP, Hennepin Health-MNCare and Hennepin Health-SNBC members.
Hennepin Health is implementing a new custom edit that will be applied to all incoming 837 professional claim transactions. This new edit will reject claims submitted with certain procedure codes when a rendering provider is required, but not included.
Hennepin County is currently experiencing an epidemic of opioid-related overdose deaths. To address this serious issue, Hennepin Health will be implementing two new limitations for opioid prescriptions effective August 1, 2018.
The surge in opioid use and misuse in the U.S. is well known and highly publicized.This webinar will introduce participants to two new resources to help address this issue in clinical practice.
Learn more about Hennepin Health's role in a performance improvement project (PIP) for reducing disparity in antidepressant medication adherence.
The referral requirements for accessing out-of-network providers differ between the ACO defined partnership network and in-network non-ACO partner providers. This FAQ provides tips and answers common questions.
Shannon Mayer, CEO of Hennepin Health since April 2014, is leaving Hennepin Health to take a new position with another Minnesota health plan. Her last day at Hennepin Health is Friday, April 20, 2018.
Hennepin Health is making several changes to its drug formulary in Q1 2018. These changes are applicable to Hennepin Health-PMAP, Hennepin Health-MNCare and Hennepin Health-SNBC members.